Multiple Assemblies exist for SMTL entry 4kba
CK1d in complex with 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine inhibitor; X-RAY DIFFRACTION 1.98 Å

	SMTL ID 4kba.1 Ligands 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine; SULFATE ION Polypeptides Casein kinase I isoform delta Oligo-state monomer
	SMTL ID 4kba.2 Ligands 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine; SULFATE ION Polypeptides Casein kinase I isoform delta Oligo-state monomer
	SMTL ID 4kba.3 Ligands 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine; SULFATE ION Polypeptides Casein kinase I isoform delta Oligo-state monomer
	SMTL ID 4kba.4 Ligands 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine; SULFATE ION Polypeptides Casein kinase I isoform delta Oligo-state monomer
	SMTL ID 4kba.5 Ligands 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine; SULFATE ION Polypeptides Casein kinase I isoform delta Oligo-state homo-dimer
	SMTL ID 4kba.6 Ligands 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine; SULFATE ION Polypeptides Casein kinase I isoform delta Oligo-state homo-dimer